Corey Smith

16PUBLICATIONS
63CO-AUTHORS
Innate immunityPreventative health careGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 03, 2026
COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced Protection.

|Jan 09, 2026
An HLA Association With COVID-19 Vaccine Reactogenicity Correlates With Fewer SARS-CoV-2 Infections and Monocyte Activation.

Jill Hollenbach, Anshika Srivastava, Demetra Chatzileontiadou

|Jan 06, 2026
A multidimensional workflow profiling of allogeneic virus-specific T cell therapies reveals potency-linked signatures.

Corey Smith, Vijayendra Dasari, Sriganesh Srihari

|Aug 22, 2025
Adoptive T-cell therapy for virus-associated diseases.

Corey Smith, Rajiv Khanna

|Jun 11, 2025
Allogeneic 'off-the-shelf' SARS-CoV-2-specific adoptive T-cell therapy for refractory viral infection and end organ disease.

Andrea S Henden, Katie E Lineburg, Archana Panikkar

|May 09, 2025
Differential reactivity of SARS-CoV-2 S-protein T-cell epitopes in vaccinated versus naturally infected individuals.

Daniel J Browne, Pauline Crooks, Corey Smith

Pageof 3

Frequent Collaborators

5 joint publications

Rajiv Khanna

4 joint publications

Katie Lineburg

4 joint publications

Stephanie Gras

2 joint publications

Gregory Marcus